Lianyungang, China

Jiangfeng Lin

This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignees: Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Medshine Discovery Inc.. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jiangfeng Lin. Retrieved from https://idiyas.com/inventor/jiangfeng-lin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 12.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jiangfeng Lin: Innovator in Bicyclic Compounds

Introduction

Jiangfeng Lin is a notable inventor based in Lianyungang, China. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on bicyclic compounds.

Latest Patents

Jiangfeng Lin holds a patent for a bicyclic compound acting as a RORγ inhibitor. This compound, represented by formula (I) or a pharmaceutically acceptable salt thereof, demonstrates good RORγ inhibitory activities. It is expected to be utilized in treating diseases mediated by RORγ receptors in mammals.

Career Highlights

Throughout his career, Jiangfeng Lin has worked with prominent companies in the pharmaceutical industry. Notable among these are Chia Tai Tianqing Pharmaceutical Group Co., Ltd. and Medshine Discovery Inc. His work in these organizations has contributed to advancements in drug development and therapeutic solutions.

Collaborations

Jiangfeng Lin has collaborated with esteemed colleagues, including Kevin X Chen and Kai Zhou. These partnerships have fostered innovation and research in the pharmaceutical sector.

Conclusion

Jiangfeng Lin's contributions to the field of bicyclic compounds and his collaborations with leading companies and professionals highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…